Category : Search result: Eric Mazumdar


Biocon Integrates Biologics Arm in $5.5 Billion Share Swap

Biocon announces full integration of its biosimilars unit, Biocon Biologics, in a deal valuing it at $5.5 billion. The move aims to create a unified powerhouse in diabetes, oncology, and immunology markets. Read more.

NYC Ends Homeless Encampment Sweeps in Policy Shift

New York City halts its controversial homeless encampment sweeps, a major policy reversal announced by Zohran Mamdani. This signals a significant break from Mayor Eric Adams's previous approach.

Ex-Dodger Gagne Pushes for Japan's MLB Stars in WBC

Former Dodgers pitcher Eric Gagne wants Shohei Ohtani, Yoshinobu Yamamoto, and Roki Sasaki to represent Japan in the 2026 World Baseball Classic, despite their heavy workload. Read his compelling reasons.

Trump Family Crypto Projects Suffer Massive Losses

Shares of Eric Trump's American Bitcoin Corp crashed over 50% in minutes, highlighting a broader collapse of Trump-linked crypto ventures. Discover the impact on the market and the 'Trump premium' turning into a drag.

Dassault Stock Up After Ukraine Leader's Meeting

Shares of Dassault Aviation saw a slight increase following a meeting between Ukraine's President and the company's CEO. Explore the stock's recent performance and market implications.

Banana Fibre Road Dividers Debate in Bengaluru

Biocon chief Kiran Mazumdar-Shaw endorses Kenyan innovation for sustainable road dividers made from compressed banana fibre, sparking intense discussion about feasibility in Bengaluru's traffic culture.

Eric Trump's Indian Remark on NYC Mayor Backfires

British journalist Mehdi Hasan exposes Eric Trump's false claim that NYC mayor-elect Zohran Mamdani 'hates Indians.' Discover the explosive online spat and Mamdani's historic election win.

Kiran Mazumdar Shaw criticized for Bengaluru praise

Biocon's Kiran Mazumdar Shaw faces online criticism after praising Bengaluru's infrastructure improvements. Residents dispute claims about roads and footpaths. Read more about the controversy.

Page 1 of 3